Among the pro-cancer immune cell populations, Tregs were significantly reduced in high LPP1-expressing tumors across all three cohorts (p < 0.001), but no consistent trends were seen for LPP2 or LPP3 (Figure S6A). This evidence concerns the gene PLPP3 and cancer.